NASDAQ: WINT
Windtree Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for WINT

Based on 1 analyst offering 12 month price targets for Windtree Therapeutics Inc

Min Forecast
$7.00+548.15%
Avg Forecast
$7.00+548.15%
Max Forecast
$7.00+548.15%

Should I buy or sell WINT stock?

Based on 1 analyst offering ratings for Windtree Therapeutics Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although WINT's forecast from analysts indicates a "Hold", our proven Zen Rating quant model rates WINT as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their WINT stock forecasts and price targets.

WINT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-12-04

1 of 1

Forecast return on equity

Is WINT forecast to generate an efficient return?

Company
N/A
Industry
1,575.97%
Market
76.96%

Forecast return on assets

Is WINT forecast to generate an efficient return on assets?

Company
N/A
Industry
1,136.33%

WINT earnings per share forecast

What is WINT's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.16

WINT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
WINT$1.08$7.00+548.15%Hold
DRMA$0.71N/AN/A
KTTA$1.43N/AN/A
JAGX$5.63N/AN/A
TCRT$2.35N/AN/A

Windtree Therapeutics Stock Forecast FAQ

Is Windtree Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: WINT) stock is to Hold WINT stock.

Out of 1 analyst, 0 (0%) are recommending WINT as a Strong Buy, 0 (0%) are recommending WINT as a Buy, 1 (100%) are recommending WINT as a Hold, 0 (0%) are recommending WINT as a Sell, and 0 (0%) are recommending WINT as a Strong Sell.

If you're new to stock investing, here's how to buy Windtree Therapeutics stock.

What is WINT's earnings growth forecast for 2025-2025?

(NASDAQ: WINT) Windtree Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 46.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.

Windtree Therapeutics's earnings in 2025 is -$5,487,000.

In 2025, WINT is forecast to generate -$7,680,858 in earnings, with the lowest earnings forecast at -$7,680,858 and the highest earnings forecast at -$7,680,858.

What is WINT's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: WINT) forecast ROE is N/A, which is considered weak.

What is WINT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year WINT price target, the average WINT price target is $7.00, with the highest WINT stock price forecast at $7.00 and the lowest WINT stock price forecast at $7.00.

The Wall Street analyst predicted that Windtree Therapeutics's share price could reach $7.00 by Dec 4, 2025. The average Windtree Therapeutics stock price prediction forecasts a potential upside of 548.15% from the current WINT share price of $1.08.

What is WINT's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: WINT) Windtree Therapeutics's current Earnings Per Share (EPS) is -$104.35. In 2025, WINT's EPS is forecast to hit -$2.16 (min: -$2.16, max: -$2.16).

What is WINT's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: WINT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 1,136.33%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.